• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从冷冻保存10年的人脐带血中高效恢复具有广泛增殖能力的未成熟造血祖细胞。

High-efficiency recovery of immature haematopoietic progenitor cells with extensive proliferative capacity from human cord blood cryopreserved for 10 years.

作者信息

Broxmeyer H E, Cooper S

机构信息

Department of Medicine (Hematology/Oncology), Indiana University School of Medicine, Indianapolis 46202-5121, USA.

出版信息

Clin Exp Immunol. 1997 Jan;107 Suppl 1:45-53.

PMID:9020936
Abstract

Cord blood is enriched with haematopoietic stem and progenitor cells which have high levels of proliferative, replating and expansion capacity in vitro. Cryopreserved cord blood stored for up to a few years has been used as a source of transplantable cells for related and unrelated allogeneic stem cell transplantation. Information on retrieval of immature and mature subsets of viable haematopoietic progenitor cells from long-term cryopreserved cord blood is not yet available. We therefore assessed the recovery of cord blood cells stored frozen in liquid nitrogen for up to 10 years. Calculations of efficiency of recovery were possible because the exact same culture conditions were used for pre-freeze and post-thaw cells with the serum and growth factors presently used being of similar potency to those used for the studies 10 years ago. High efficiency recovery of immature and mature progenitors was found even though a relatively unsophisticated freezing procedure had been used. Recovery of nucleated cells averaged 88% and that of granulocyte-macrophage (CFU-GM), erythroid (BFU-E) and multipotential (CFU-GEMM) progenitors averaged from 74 to 91% for different populations, with some samples in each category being recovered at 100%. Recovery of immature progenitors responsive to stimulation in vitro with a colony stimulating factor plus the potent co-stimulating cytokine, steel factor, was also demonstrated, although the per cent recovery of such cells could not be calculated directly as steel factor was not available 9-10 years ago when the cells were originally frozen. While the cell populations assayed are not considered to represent long-term narrow repopulating cells, the data presented demonstrate that cells with very high proliferative capacity can be stored long term in cryopreserved form.

摘要

脐血富含造血干细胞和祖细胞,这些细胞在体外具有高水平的增殖、再植和扩增能力。储存数年的冷冻保存脐血已被用作相关和无关异体干细胞移植的可移植细胞来源。关于从长期冷冻保存的脐血中获取存活造血祖细胞的未成熟和成熟亚群的信息尚不可用。因此,我们评估了在液氮中冷冻保存长达10年的脐血细胞的回收率。由于对冻前和冻后细胞使用了完全相同的培养条件,且目前使用的血清和生长因子的效力与10年前研究中使用的相似,所以可以计算回收率。尽管使用了相对简单的冷冻程序,但仍发现未成熟和成熟祖细胞的回收率很高。有核细胞的回收率平均为88%,粒细胞 - 巨噬细胞(CFU - GM)、红系(BFU - E)和多能(CFU - GEMM)祖细胞的回收率在不同群体中平均为74%至91%,每个类别中的一些样本回收率达到100%。还证明了对集落刺激因子加有效共刺激细胞因子(钢因子)体外刺激有反应的未成熟祖细胞的回收率,尽管由于10年前细胞最初冷冻时没有钢因子,无法直接计算此类细胞的回收率。虽然所检测的细胞群体不被认为代表长期窄谱系再填充细胞,但所呈现的数据表明,具有非常高增殖能力的细胞可以以冷冻保存的形式长期储存。

相似文献

1
High-efficiency recovery of immature haematopoietic progenitor cells with extensive proliferative capacity from human cord blood cryopreserved for 10 years.从冷冻保存10年的人脐带血中高效恢复具有广泛增殖能力的未成熟造血祖细胞。
Clin Exp Immunol. 1997 Jan;107 Suppl 1:45-53.
2
The effect of different thawing methods, growth factor combinations and media on the ex vivo expansion of umbilical cord blood primitive and committed progenitors.不同解冻方法、生长因子组合及培养基对脐血原始祖细胞和定向祖细胞体外扩增的影响。
Bone Marrow Transplant. 1998 Feb;21(3):233-41. doi: 10.1038/sj.bmt.1701088.
3
Density separation of umbilical cord blood and recovery of hemopoietic progenitor cells: implications for cord blood banking.脐带血的密度分离及造血祖细胞的回收:对脐带血库的意义
Stem Cells. 1995 Sep;13(5):533-40. doi: 10.1002/stem.5530130511.
4
[Effects of different cooling rates on cryopreservation of hematopoietic stem cells from cord blood].不同降温速率对脐血造血干细胞冷冻保存的影响
Sheng Wu Gong Cheng Xue Bao. 2003 Jul;19(4):489-92.
5
Clonogenic capacity and ex vivo expansion potential of umbilical cord blood progenitor cells are not impaired by cryopreservation.脐血祖细胞的克隆形成能力和体外扩增潜力不会因冷冻保存而受损。
Bone Marrow Transplant. 1997 Jun;19(11):1079-84. doi: 10.1038/sj.bmt.1700803.
6
Effects of long-term cryopreservation on hematopoietic progenitor cells in umbilical cord blood.长期冷冻保存对脐带血中造血祖细胞的影响。
Bone Marrow Transplant. 1999 Feb;23(4):395-6. doi: 10.1038/sj.bmt.1701580.
7
[Umbilical cord blood as a source of stem cells].[脐带血作为干细胞的来源]
Acta Med Croatica. 2006 Jun;60(3):215-25.
8
Cord blood stem and progenitor cells.脐带血干细胞和祖细胞。
Methods Enzymol. 2006;419:439-73. doi: 10.1016/S0076-6879(06)19018-7.
9
Highly efficient gene transfer into preterm CD34 hematopoietic progenitor cells.高效基因转移至早产CD34造血祖细胞。
Am J Obstet Gynecol. 2000 Sep;183(3):732-7. doi: 10.1067/mob.2000.106752.
10
Uncontrolled-rate freezing of peripheral blood progenitor cells allows successful engraftment by sparing primitive and committed hematopoietic progenitors.外周血祖细胞的无控制速率冷冻通过保留原始和定向造血祖细胞实现成功植入。
Haematologica. 2003 Dec;88(12):1390-5.

引用本文的文献

1
Restoring mitochondrial function promotes hematopoietic reconstitution from cord blood following cryopreservation-related functional decline.恢复线粒体功能可促进冷冻保存相关功能衰退后脐带血的造血重建。
J Clin Invest. 2025 Mar 4;135(9). doi: 10.1172/JCI183607. eCollection 2025 May 1.
2
Insights into highly engraftable hematopoietic cells from 27-year cryopreserved umbilical cord blood.从 27 年深低温冻存的脐带血中获得具有高植入能力的造血细胞的见解。
Cell Rep Med. 2023 Nov 21;4(11):101259. doi: 10.1016/j.xcrm.2023.101259. Epub 2023 Oct 31.
3
High Integrity and Fidelity of Long-Term Cryopreserved Umbilical Cord Blood for Transplantation.
长期冷冻保存的脐带血用于移植的高完整性和高保真度。
J Clin Med. 2021 Jan 14;10(2):293. doi: 10.3390/jcm10020293.
4
How old is too old? engraftment of human peripheral blood stem cells cryopreserved for up to 18 years - implications for clinical transplantation and stability programs.多大年龄算太大?人类外周血干细胞冷冻保存长达18年的植入——对临床移植和稳定性计划的影响
World J Stem Cells. 2020 May 26;12(5):359-367. doi: 10.4252/wjsc.v12.i5.359.
5
Past, present, and future efforts to enhance the efficacy of cord blood hematopoietic cell transplantation.过去、现在及未来提高脐血造血细胞移植疗效的努力。
F1000Res. 2019 Oct 31;8. doi: 10.12688/f1000research.20002.1. eCollection 2019.
6
Enhancing the efficacy of engraftment of cord blood for hematopoietic cell transplantation.提高脐带血用于造血细胞移植的植入疗效。
Transfus Apher Sci. 2016 Jun;54(3):364-72. doi: 10.1016/j.transci.2016.05.013. Epub 2016 May 12.
7
Umbilical cord blood transplantation supplemented with the infusion of mesenchymal stem cell for an adolescent patient with severe aplastic anemia: a case report and review of literature.脐带血移植联合间充质干细胞输注治疗一名青少年重型再生障碍性贫血患者:病例报告及文献复习
Patient Prefer Adherence. 2015 Jun 11;9:759-65. doi: 10.2147/PPA.S81509. eCollection 2015.
8
Usefulness of umbilical cord blood cells in era of hematopoiesis research.脐带血细胞在造血研究时代的应用。
Int J Stem Cells. 2009 May;2(2):90-6. doi: 10.15283/ijsc.2009.2.2.90.
9
Quality of cord blood cryopreserved for up to 5 years.冷冻保存长达5年的脐带血质量。
Blood Res. 2014 Mar;49(1):54-60. doi: 10.5045/br.2014.49.1.54. Epub 2014 Mar 24.
10
Counteracting the enzymatic activity of dipeptidylpeptidase 4 for potential therapeutic advantage, with an emphasis on cord blood transplantation.针对二肽基肽酶 4 的酶活性进行拮抗,以获得潜在的治疗优势,重点关注脐血移植。
Korean J Intern Med. 2013 Nov;28(6):639-45. doi: 10.3904/kjim.2013.28.6.639. Epub 2013 Oct 29.